Clinical Trial Update: H-36731: Finasteride in Management of Elevated Red Blood Cells [Phase 3]

View source ↗

Summary

A Phase 3 trial of finasteride for erythrocytosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythrocytosis

Drugs mentioned

• FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: Baylor College of Medicine | Conditions: ERYTHROCYTOSIS | Phase 3 | Status: WITHDRAWN